Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy

Fig. 3

MET positively correlates with PD-L1 in PDAC patients. A-C Protein expression levels (A) as well as quantifications (B and C) of MET and PD-L1 in 10 paired PDAC and adjacent noncancerous tissue specimens as assessed by Western blotting (T, tumor; N, normal). D Quantitative correlation between MET and PD-L1 protein levels in paired PDAC and adjacent normal tissues. E Representative images of immunohistochemical staining for MET and PD-L1 in PDAC tissue array. Scale bar, 50 μm. F Quantitative correlation between MET and PD-L1 protein levels in PDAC tissue microarray. G Kaplan–Meier survival curves of MET–PD-L1 protein level-based OS in PDAC patients

Back to article page